Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|
EBITDA | $12.1M | ($16.1M) | $78.9M | $103.8M |
Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|
% growth | 500.1 0.0% | 564.1 12.8% | 728.7 29.2% | 963.7 32.3% |
Cost of Goods Sold (COGS) | 462.5 | 508.9 | 548.4 | 317.3 |
% margin | 37.6 7.5% | 55.3 9.8% | 180.3 24.7% | 646.4 67.1% |
Operating Expenses | 64.8 | 70.0 | 175.6 | 404.6 |
Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative Expenses (SG&A) | 64.8 | 70.0 | 101.5 | 120.5 |
% margin | (27.2) (5.4%) | (14.8) (2.6%) | 4.7 0.6% | 43.1 4.5% |
Interest Income | 0.0 | 0.0 | 8.9 | 0.0 |
Interest Expense | 4.8 | 0.0 | 0.0 | 0.0 |
Pre-tax Income | (37.3) | (58.9) | 14.0 | 59.9 |
% effective tax rate | 0.1 (0.3%) | 0.1 (0.2%) | 0.8 5.5% | (70.4) (117.5%) |
% margin | (37.4) (7.5%) | (59.0) (10.5%) | 13.3 1.8% | 130.3 13.5% |
EPS | (0.33) | (0.52) | 0.22 | 1.14 |
Diluted EPS | (0.33) | (0.52) | 0.21 | 1.10 |
% margin | 12.1 2.4% | (16.1) (2.9%) | 78.9 10.8% | 103.8 10.8% |
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
As of today, CAVA Group, Inc.'s last 12-month EBITDA is $117.6M, based on the financial report for Dec 29, 2024 (Q4’2024).
Over the last year, CAVA Group, Inc.'s EBITDA growth was 106.5%. The average annual EBITDA growth rates for CAVA Group, Inc. have been N/A over the past three years, N/A over the past five years.
Over the last year, CAVA Group, Inc.'s EBITDA growth was 106.5%, which is higher than industry growth of 0.1%. It indicates that CAVA Group, Inc.'s EBITDA growth is Good.